Viewpoint

The COVID-19 pandemic provides a stark illustration of why we need effective tools for sharing health data in Europe, say four MEPs

The biggest problem in finding a cure or vaccine isn’t money. It’s lack of coordination. We need a better way of identifying the global research gaps for this 21st century Manhattan Project of health

An open-science advocate sees lessons for how science and policy should interact, if we want to recover from and prevent future health disasters

This won’t be the last big global health crisis, warns Pierre Meulien, director of the EU’s Innovative Medicines Initiative

Now more than ever, international cooperation is needed to fight back against the pandemic. A protectionist approach to R&D will serve no one’s interests

Former EU chief science adviser Anne Glover discusses the UK’s handling of the COVID-19 epidemic and if the European Commission is lacking scientific leadership during the crisis

The EU’s new industrial strategy, with its aim of driving innovation in advanced technologies, could lead to established economic development policies being seen as outdated. But tried-and-tested approaches, especially Cohesion policy, have complementary objectives - and an important role to play

Pierre Meulien, director of the Innovative Medicines Initiative wants to see pooling of international research efforts to help curb the spread of COVID-19 and develop treatments for the respiratory infection it causes

Draft of climate law released this week is the first test of the European Green Deal. Success now rests on reshaping each aspect of EU policy

Finding a compromise on the EU’s next budget is no doubt a highly complex task. But after the lean years since the 2008 crash, there must be a commitment to increasing investment in research, innovation and higher education